Skip to content

Feasibility study: an investigation of frailty and glycaemic control in older adults with type 1 diabetes mellitus

Feasibility study: an investigation of frailty and glycaemic control in older adults with type 1 diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN14616896
Enrollment
20
Registered
2023-04-03
Start date
2022-09-14
Completion date
Unknown
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes Nutritional, Metabolic, Endocrine

Interventions

It is clear that in older people with type 1 diabetes (T1DM), there is a real and genuine fear of how their diabetes management will continue if/when they become less able to manage it themselves as p

Sponsors

University Hospitals Sussex NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients over the age of 65 years old with an established diagnosis of type 1 diabetes of at least one-year duration.

Exclusion criteria

Exclusion criteria: Inability to understand or comply with requirements of the study, including cognitive impairment to a degree that capacity is impaired (investigator opinion).

Design outcomes

Primary

MeasureTime frame
Feasibility assessed during the study period using study records: 1. How well the recruitment strategy works in practice measured using the number of participants referred 2. What percentage of eligible participants are recruited for the study measured using the number of participants that are recruited compared to the number referred 3. Time to first and last recruitment measured using the length it takes to recruit the 20 participants 4. Attrition rate measured using the number of participants that do not complete the study after starting it 5. Adherence to the continuous glucose monitoring (CGM) device – For example how much data is lost when the receiver is out of range - measured by the percentage of CGM captured during the 10-day monitoring period The recruitment strategy and protocol will be deemed a success if the following are met: 1. At least 30% of eligible participants recruited to the study 2. No more than a 10% attrition rate 3. At least 70% adherence to CGM

Secondary

MeasureTime frame
Patient experience, acceptability, and feasibility of the use of the continuous glucose monitoring device measured using bespoke questionnaires at the end of the study

Countries

England, United Kingdom

Contacts

Public ContactJonathan Golding
jonathan.golding1@nhs.net+44 (0)1273 696955 ext 67613

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026